Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences

Imaging and radiotherapy targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR) could potentially benefit the management of neuroendocrine neoplasms (NENs), complementing clinically established radiopharmaceuticals. The aim of this study was to evaluate a GIPR-targeting positron...

Descripción completa

Detalles Bibliográficos
Autores principales: Velikyan, Irina, Bossart, Martin, Haack, Torsten, Laitinen, Iina, Estrada, Sergio, Johansson, Lars, Pierrou, Stefan, Wagner, Michael, Eriksson, Olof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864903/
https://www.ncbi.nlm.nih.gov/pubmed/36678558
http://dx.doi.org/10.3390/ph16010061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864903/
https://www.ncbi.nlm.nih.gov/pubmed/36678558
http://dx.doi.org/10.3390/ph16010061

Ejemplares similares